Pure Biologics S.A.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors (NCT06700070) | Pure Biologics S.A. | 2025-03-27 |
Track Pure Biologics S.A. automatically
Every clearance here is in the API, with alerts when new ones post.